Saturday 17 October 2026
Export AORT’s income statement to Excel — free account
Artivion, Inc.
AORT Healthcare Medical Devices
Artivion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $441.3 million, up 13.6% from fiscal 2024. In the quarter to June 2026, revenue grew 11.3%, EPS fell 1,033.3%, free cash flow fell 202.5% and total debt rose 67.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.
21.78
0.09
−0.41%
Follow AORT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(2.45%) | 2.69% | 3.14% | (0.73%) | |
Piotroski F-Score |
5 | 7 | 7 | 4 | |
| (1.10%) | 1.17% | 1.40% | (0.33%) | ||
ROIC |
2.76% | 3.51% | 3.81% | 1.76% | |
Return on Tangible Assets |
(3.12%) | 3.03% | 3.51% | (0.94%) | |
Average Days of Receivables |
84.09 | 85.75 | 84.05 | 85.75 | |
Free Cash Flow per Share |
0.37 | 0.02 | 0.30 | (0.19) | |
Free Cash Flow |
17.50 | 0.84 | 14.58 | (9.16) | |
Capital Expenditures |
(12.96) | (39.04) | (43.41) | (50.87) | |
| Other line items | |||||
Cash ROIC |
2.40% | 0.11% | 2.01% | (1.03%) | |
Accounts Receivable Turnover |
4.82 | 4.66 | 4.56 | 4.45 | |
Accounts Payable Turnover |
10.86 | 9.24 | 10.83 | 8.34 | |
Inventory Turnover |
1.72 | 1.82 | 1.81 | 1.77 | |
Average Days of Payables |
40.12 | 37.27 | 41.16 | 45.35 | |
Days of Inventory on Hand |
220.24 | 214.74 | 219.99 | 224.61 | |
Tax Rate |
0.09 | (0.34) | (0.33) | (2.42) | |
Research and Development Expense of Revenue |
6.93% | 7.02% | 7.22% | 7.44% | |
Selling, General and Administrative Expense of Revenue |
52.31% | 51.32% | 50.71% | 54.04% | |
Share Based Compensation of Revenue |
5.45% | 5.53% | 5.40% | 5.68% | |
Interest Coverage |
0.84 | 1.27 | 1.54 | 0.85 | |
Operating CF/Net income |
(3.34) | 4.09 | 4.97 | (13.13) | |
Depreciation/Fixed assets |
0.56 | 0.35 | 0.34 | 0.33 | |
Capex/Depreciation |
(0.56) | (1.74) | (1.86) | (2.07) | |
Revenue per Share |
8.95 | 9.73 | 9.54 | 9.71 | |
Operating CF per Share |
0.64 | 0.88 | 1.21 | 0.86 | |
Capex per Share |
(0.27) | (0.86) | (0.90) | (1.05) | |
Capex to Sales |
0.03 | 0.09 | 0.09 | 0.11 |
Columns are period end dates